Dingwei Ye

25PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersGenome structure and regulationCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 12, 2026
METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation.

|Apr 18, 2026
Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations.

|Apr 01, 2026
Integrating China's Oncology Innovations into the Global Landscape: A Strategic Blueprint for Precision, Partnership, and Purpose.

Xudong Ni, Tingwei Zhang, Andrea Necchi

|Oct 08, 2025
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial.

Xiaojie Bian, Tiejun Yang, Huaqi Yin

|Sep 22, 2025
KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer.

Haoyue Sheng, Guohai Shi, Yawen Lu

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

Pageof 5

Frequent Collaborators

5 joint publications

Matthew D Galsky

4 joint publications

Hailiang Zhang

4 joint publications

Neeraj Agarwal

3 joint publications

Yao Zhu